Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mrs Jenny Bellorini, Managing Editor in the Cochrane ENT Disorders Group which is hosted by the Nuffield Department of Surgical Sciences, has won the 2015 Chris Silagy Prize.

Chris Silagy (1960-2001) was the founding Director of the Australasian Cochrane Centre, a former Chair of the Cochrane Steering Group and instrumental in Cochrane's development and success. Before his death in 2001, he initiated a fund to recognise contributions to The Cochrane Collaboration in ways that are often insufficiently recognised.

The Chris Silagy Prize is awarded at every Cochrane Colloquium to an individual (or organisation) who has made an extraordinary contribution to the work of the Collaboration.

Chris Silagy Prize 2015Mrs Bellorini is a worthy winner of this year's prize. She has copy edited at least 1500 Cochrane reviews and protocols through the Cochrane copy edit support team. This is in addition to her work as the Managing Editor of the Ears, Nose and Throat Review Group.

She was described in her nomination statement as ‘someone who exemplifies quiet reliability, is highly respected and sought out by her peers, and she demonstrates tremendous dedication to carrying out key editorial roles at a consistently high standard over the course of many years.’

The Chris Silagy Prize was presented to Mrs Bellorini by Denise Thomson, the recipient of the 2014 prize, during the Annual General Meeting held at the Vienna Colloquium, 3-7 October 2015, and consists of AU$1,000, a certificate and expenses associated with attending the Colloquium.

Watch the presentation of the prize, which starts at around 1:56:30 on the video.

For more information about Cochrane ENT, visit the Cochrane ENT research page on the NDS website and the main Cochrane ENT website.

Similar stories

Sheraz Markar awarded Associate Professor title

We are very pleased to announce that Sheraz Markar has been awarded the title of Associate Professor by the University of Oxford.

New Associate Professor at NDS

The Nuffield Department of Surgical Sciences (NDS) is very happy to report that Joanna Hester has been promoted to Associate Professor.

Professor Martin Burton elected as Master of Sidney Sussex College, Cambridge

Professor Martin Burton, Professor of Otolaryngology in Oxford University’s Nuffield Department of Surgical Sciences (NDS) and Director of Cochrane UK, has been elected as the next Master of Sidney Sussex College at the University of Cambridge.

Blog posts

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.